![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Cell Biochemistry, Hannah Research Institute, Ayr, KA6 5HL, Scotland and * CSIRO, Health Sciences and Nutrition, Adelaide BC, SA 5000, Australia
3To whom correspondence should be addressed. E-mail: zammitv{at}hri.sari.ac.uk.
The recent observations that insulin can either stimulate or inhibit triacylglycerol secretion by the liver, depending on prior metabolic (possibly insulinemic) state, have rationalized the many apparently contradictory observations, obtained over the past three decades, on the effects of the hormone on this aspect of hepatic metabolism. Extrapolation to the situation in vivo suggests that frequent stimulation of insulin secretion may result in a chronic stimulation of VLDL secretion, and increased delivery of acyl moieties to muscle, where they induce insulin resistance if provided in excess of the oxidative needs (mostly due to exercise) of the tissue. High fructose/sucrose diets, which also stimulate hepatic VLDL secretion, will have the same effect, especially if consumed frequently during the diurnal cycle. Due to the quantitative importance of muscle as a site for insulin-sensitive glucose metabolism, these effects may initiate the metabolic vicious cycle that results in the development of the metabolic syndrome, well in advance of overt obesity or the diagnosis of type-2 diabetes.
KEY WORDS: • insulin resistance • obesity • type-2 diabetes • liver • VLDL • triacylglycerol
This article has been cited by other articles:
|
|
 |
|
  W. Huang, A. Metlakunta, N. Dedousis, H. K. Ortmeyer, M. Stefanovic-Racic, and R. M. O'Doherty Leptin Augments the Acute Suppressive Effects of Insulin on Hepatic Very Low-Density Lipoprotein Production in Rats Endocrinology, May 1, 2009; 150(5): 2169 - 2174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Johnson, S. E. Perez-Pozo, Y. Y. Sautin, J. Manitius, L. G. Sanchez-Lozada, D. I. Feig, M. Shafiu, M. Segal, R. J. Glassock, M. Shimada, et al. Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes? Endocr. Rev., February 1, 2009; 30(1): 96 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J Johnson, M. S Segal, Y. Sautin, T. Nakagawa, D. I Feig, D.-H. Kang, M. S Gersch, S. Benner, and L. G Sanchez-Lozada Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease Am. J. Clinical Nutrition, October 1, 2007; 86(4): 899 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. G. Neilson The Fructose Nation J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2619 - 2621. [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Hammond, S. Neschen, A. J. Romanelli, G. W. Cline, O. R. Ilkayeva, G. I. Shulman, D. M. Muoio, and R. A. Coleman Mitochondrial Glycerol-3-phosphate Acyltransferase-1 Is Essential in Liver for the Metabolism of Excess Acyl-CoAs J. Biol. Chem., July 8, 2005; 280(27): 25629 - 25636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cordain, S B. Eaton, A. Sebastian, N. Mann, S. Lindeberg, B. A Watkins, J. H O'Keefe, and J. Brand-Miller Origins and evolution of the Western diet: health implications for the 21st century Am. J. Clinical Nutrition, February 1, 2005; 81(2): 341 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nagao, N. Inoue, Y.-M. Wang, B. Shirouchi, and T. Yanagita Dietary Conjugated Linoleic Acid Alleviates Nonalcoholic Fatty Liver Disease in Zucker (fa/fa) Rats J. Nutr., January 1, 2005; 135(1): 9 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Sugden and M. J. Holness Potential Role of Peroxisome Proliferator-Activated Receptor-{alpha} in the Modulation of Glucose-Stimulated Insulin Secretion Diabetes, February 1, 2004; 53(90001): S71 - 81. [Abstract] [Full Text]
|
|
|
|
|
|
K. S Juntunen, D. E Laaksonen, K. Autio, L. K Niskanen, J. J Holst, K. E Savolainen, K.-H. Liukkonen, K. S Poutanen, and H. M Mykkanen Structural differences between rye and wheat breads but not total fiber content may explain the lower postprandial insulin response to rye bread Am. J. Clinical Nutrition, November 1, 2003; 78(5): 957 - 964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Cordain, S. Lindeberg, M. Hurtado, K. Hill, S. B. Eaton, and J. Brand-Miller Acne Vulgaris: A Disease of Western Civilization Arch Dermatol, December 1, 2002; 138(12): 1584 - 1590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Mattes Oral Fat Exposure Increases the First Phase Triacylglycerol Concentration Due to Release of Stored Lipid in Humans J. Nutr., December 1, 2002; 132(12): 3656 - 3662. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Sunehag, G. Toffolo, M. S. Treuth, N. F. Butte, C. Cobelli, D. M. Bier, and M. W. Haymond Effects of Dietary Macronutrient Content on Glucose Metabolism in Children J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5168 - 5178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Frick, D. Linden, C. Ameen, S. Eden, A. Mode, and J. Oscarsson Interaction between growth hormone and insulin in the regulation of lipoprotein metabolism in the rat Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1023 - E1031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Sharman, W. J. Kraemer, D. M. Love, N. G. Avery, A. L. Gomez, T. P. Scheett, and J. S. Volek A Ketogenic Diet Favorably Affects Serum Biomarkers for Cardiovascular Disease in Normal-Weight Men J. Nutr., July 1, 2002; 132(7): 1879 - 1885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. J. Waterman and V. A. Zammit Differential Effects of Fenofibrate or Simvastatin Treatment of Rats on Hepatic Microsomal Overt and Latent Diacylglycerol Acyltransferase Activities Diabetes, June 1, 2002; 51(6): 1708 - 1713. [Abstract] [Full Text] [PDF]
|
|
